By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Intrexon Corporation 

20374 Seneca Meadows Parkway

Germantown  Maryland  20876  U.S.A.
Phone: 301-556-9900 Fax: 301-556-9901


Through the engineering of biology, Intrexon is helping to address some of the world’s most pressing challenges and is working with industry and government leaders to realize a better, healthier planet. Today our platform is delivering novel therapies in health, supplying unique solutions to address global energy demand, developing unparalleled productivity advancements in food, creating innovative applications for consumers, and helping to restore and protect the environment.

To execute on its mission, Intrexon has integrated a suite of technologies and expertise across a number of cellular platforms to drive the start-to-finish conceptualization and production of bio-based solutions. At our foundation is the ability to systematically program the most pervasive code on the planet – DNA – to deliver unprecedented control over the quality, function, and performance of living cells. Our programming expertise spans multiple host systems (human, animal, insect, plant, fungi, and bacteria) opening the door to synthetic biology’s considerable potential and differentiating us from many other organizations in the field.

Through collaboration, our proprietary approach to genetic programming enables partners to construct biologically based products designed to provide a competitive edge including time to market, cost of production, and quality. Together, Intrexon and our collaborators are building solutions to challenging issues across fields as diverse as medicine, fuel, agriculture, nutrition, personal care, chemicals, and manufacturing helping forge a sustainable path forward for current and future generations. We call our approach Better DNA® and invite you to discover more at or follow us on Twitter at @Intrexon, on Facebook and LinkedIn.

Key Statistics

Ownership: Public

Web Site: Intrexon
Symbol: XON


Company News
Intrexon (XON) Announces Second Quarter and First Half 2016 Financial Results 8/10/2016 9:58:04 AM
Intrexon (XON) Appoints Dr. Andrew J. Last As Chief Operating Officer 8/8/2016 6:57:09 AM
Intrexon (XON) To Announce Second Quarter And First Half 2016 Financial Results On August 9th 8/2/2016 8:26:05 AM
Intrexon (XON) Introduces Florian Switch Technology For Flowering Control 7/25/2016 7:47:35 AM
Intrexon (XON) Appoints Fred Hassan, Distinguished Life Sciences Executive, To Board Of Directors 7/1/2016 6:58:58 AM
Intrexon (XON) To Present At The JMP Securities Life Sciences Conference 6/20/2016 7:30:29 AM
Intrexon (XON) To Present At The Jefferies 2016 Healthcare Conference 6/10/2016 10:38:26 AM
Intrexon (XON) Announces Retirement Of Samuel Broder, M.D., Head Of Health Sector 6/6/2016 11:39:37 AM
Intrexon (XON) To Present At Upcoming Investor And Industry Conferences 5/23/2016 7:51:17 AM
Journalist Criticizes ZIOPHARM Oncology (ZIOP.OB) as Its Own ‘Biotech Bubble’ Held Aloft by Ties to R.J. Kirk's Intrexon (XON) 5/20/2016 5:59:59 AM